Integrative Analysis Reveals a miRNA-mRNA Regulatory Network and Potential Causative Agents in the Asthmatic Airway Epithelium

References

• Zhang J, Dong L. Status and prospects: personalized treatment and biomarker for airway remodeling in asthma. J Thorac Dis. 2020;12(10):6090–6101. doi:10.21037/jtd-20-1024
   Web of Science ®Google Scholar
• Bonato M, Gallo E, Bazzan E, et al. Air pollution relates to airway pathology in wheezing children. Ann Am Thorac Soc. 2021. doi:10.1513/AnnalsATS.202010-1321OC
   Web of Science ®Google Scholar
• Abu-Kishk I, Polakow-Farkash S, Elizur A. Long-term outcome after pediatric intensive care unit asthma admissions. Allergy Asthma Proc. 2016;37(6):169–175. doi:10.2500/aap.2016.37.4008
   Web of Science ®Google Scholar
• Arshad S, Hodgekiss C, Holloway J, et al. Association of asthma and smoking with lung function impairment in adolescence and early adulthood: the Isle of Wight Birth Cohort Study. Eur Respir J. 2020;55(3):1900477. doi:10.1183/13993003.00477-2019
   PubMed Web of Science ®Google Scholar
• Chiu C, Huang M. Asthma in the precision medicine era: biologics and probiotics. Int J Mol Sci. 2021;22(9):4528. doi:10.3390/ijms22094528
   PubMed Web of Science ®Google Scholar
• Hewitt R, Lloyd C. Regulation of immune responses by the airway epithelial cell landscape. Nat Rev Immunol. 2021;21:347–362. doi:10.1038/s41577-020-00477-9
   PubMed Web of Science ®Google Scholar
• Stefano L, Rössler OG, Griesemer D, Hoth M, Thiel G. P2X(7) receptor stimulation upregulates Egr-1 biosynthesis involving a cytosolic Ca(2+) rise, transactivation of the EGF receptor and phosphorylation of ERK and Elk-1. J Cell Physiol. 2007;213(1):36–44. doi:10.1002/jcp.21085
   Web of Science ®Google Scholar
• Akdis C. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol. 2021. doi:10.1038/s41577-021-00538-7
   Web of Science ®Google Scholar
• Incorvaia C, Al-Ahmad M, Ansotegui I, et al. Personalized medicine for allergy treatment: allergen immunotherapy still a unique and unmatched model. Allergy. 2021;76(4):1041–1052. doi:10.1111/all.14575
   Web of Science ®Google Scholar
• Cushing L, Jiang Z, Kuang P, Lü J. The roles of microRNAs and protein components of the microRNA pathway in lung development and diseases. Am J Respir Cell Mol Biol. 2015;52(4):397–408. doi:10.1165/rcmb.2014-0232RT
   PubMed Web of Science ®Google Scholar
• Szymczak I, Wieczfinska J, Pawliczak R. Molecular background of miRNA role in asthma and COPD: an updated insight. Biomed Res Int. 2016;2016:7802521. doi:10.1155/2016/7802521
   PubMed Web of Science ®Google Scholar
• Boulet L, Reddel H, Bateman E, Pedersen S, FitzGerald J, O’Byrne P. The Global Initiative for Asthma (GINA): 25 years later. Eur Respir J. 2019;54(2):1900598. doi:10.1183/13993003.00598-2019
   PubMed Web of Science ®Google Scholar
• Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicombe SM, Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol. 2000;105(2 Pt 1):193–204. doi:10.1016/S0091-6749(00)90066-6
   PubMed Web of Science ®Google Scholar
• Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med. 2012;18(5):684–692. doi:10.1038/nm.2737
   PubMed Web of Science ®Google Scholar
• Yang Y, Man J, Yingwei O, Adcock IM, Xin Y. Mechanisms and biomarkers of airway epithelial cell damage in asthma: a review. Clin Respir J. 2021;15:1027–1045. doi:10.1111/crj.13407
   Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–854. doi:10.1016/0092-8674(93)90529-Y
   PubMed Web of Science ®Google Scholar
• Weidner J, Bartel S, Kılıç A, et al. Spotlight on microRNAs in allergy and asthma. Allergy. 2020;76(6):1661–1678.
   Web of Science ®Google Scholar
• Siddiqui S, Johansson K, Joo A, et al. Epithelial miR-141 regulates IL-13-induced airway mucus production. JCI Insight. 2021;6(5). doi:10.1172/jci.insight.139019.
   Web of Science ®Google Scholar
• Moheimani F, Koops J, Williams T, et al. Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics. Respir Res. 2018;19(1):145. doi:10.1186/s12931-018-0851-7
   PubMed Web of Science ®Google Scholar
• Bartel S, La Grutta S, Cilluffo G, et al. Human airway epithelial extracellular vesicle miRNA signature is altered upon asthma development. Allergy. 2020;75(2):346–356. doi:10.1111/all.14008
   PubMed Web of Science ®Google Scholar
• Jia G, Erickson R, Choy D, et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol. 2012;130(3):647–654.e610. doi:10.1016/j.jaci.2012.06.025
   PubMed Web of Science ®Google Scholar
• Burgess J, Jonker M, Berg M, et al. Periostin: contributor to abnormal airway epithelial function in asthma? Eur Respir J. 2021;57(2):2001286. doi:10.1183/13993003.01286-2020
   Web of Science ®Google Scholar
• Izuhara K, Conway S, Moore B, et al. Roles of periostin in respiratory disorders. Am J Respir Crit Care Med. 2016;193(9):949–956. doi:10.1164/rccm.201510-2032PP
   PubMed Web of Science ®Google Scholar
• Inoue T, Akashi K, Watanabe M, et al. Periostin as a biomarker for the diagnosis of pediatric asthma. Pediatr Allerg Immunol. 2016;27(5):521–526. doi:10.1111/pai.12575
   Web of Science ®Google Scholar
• Mansur A, Srivastava S, Sahal A. Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function. Respir Med. 2018;143:31–38. doi:10.1016/j.rmed.2018.08.005
   PubMed Web of Science ®Google Scholar
• Song J, You J, Jeong S, et al. Serum periostin levels correlate with airway hyper-responsiveness to methacholine and mannitol in children with asthma. Allergy. 2015;70(6):674–681. doi:10.1111/all.12599
   PubMed Web of Science ®Google Scholar
• Hanania N, Korenblat P, Chapman K, et al. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med. 2016;4(10):781–796. doi:10.1016/S2213-2600(16)30265-X
   PubMed Web of Science ®Google Scholar
• Buhl R, Korn S, Menzies-Gow A, et al. Prospective, single-arm, longitudinal study of biomarkers in real-world patients with severe asthma. J Allergy Clin Immunol Pract. 2020;8(8):2630–2639.e2636. doi:10.1016/j.jaip.2020.03.038
   PubMed Web of Science ®Google Scholar
• Licari A, Brambilla I, Sacchi L, Marseglia G, Ciprandi G. Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children. Respir Med. 2019;151:118–120. doi:10.1016/j.rmed.2019.04.010
   PubMed Web of Science ®Google Scholar
• Castro-Rodriguez J, Atton I, Villarroel G, Serrano C. Serum periostin is not related to asthma predictive index. Allergologia et Immunopathol. 2018;46(3):235–240. doi:10.1016/j.aller.2017.05.012
   Web of Science ®Google Scholar
• Anderson H, Lemanske R, Arron J, et al. Relationships among aeroallergen sensitization, peripheral blood eosinophils, and periostin in pediatric asthma development. J Allergy Clin Immunol. 2017;139(3):790–796. doi:10.1016/j.jaci.2016.05.033
   PubMed Web of Science ®Google Scholar